Abstract Treatment resistance, together with acute and late adverse effects, represents
critical issues in the management of cancer patients. Promising results from preclinical and …

Acute graft-versus-host disease (aGVHD) is a major life-threatening complication after
allogeneic hematopoietic cell transplant. Traditional standard prophylaxis for aGVHD has …

This review explores the complex relationship between gut dysbiosis and hematological
malignancies, focusing on graft-versus-host disease (GvHD) in allogeneic hematopoietic …

Microbiota changes during allogeneic hematopoietic stem cell transplantation has several
known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic …

In the companion to this article, Rashidi et al 1 report the results of a randomized trial of fecal
microbiota transplantation (FMT) in recipients of induction chemotherapy for acute leukemia …

Background: Acute graft-versus-host disease (GvHD) is a major and sometimes lethal
complication following allogeneic stem cell transplantation (aSCT). In the last 10 years, a …

Allogeneic hematopoietic stem cell transplantation is one of the most effective treatment
strategies for leukemia, lymphoma, and other hematologic malignancies. However, graft …

The human intestine hosts a complex ecosystem of various microorganisms, collectively
known as the gut microbiome, which significantly impacts human health. Disruptions in the …

Abstract Acute Graft versus Host Disease (aGvHD) is a common immunological complication
occurring in patients undergoing allogeneic hematopoietic stem cell transplantation (allo …

The burgeoning field of pharmacomicrobiomics offers promising insights into the intricate
interplay between the microbiome and cancer, shaping responses to diverse treatment …